Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-059678
Filing Date
2025-06-30
Accepted
2025-06-30 16:20:40
Documents
114
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0247442-6k_gelteq.htm   iXBRL 6-K 21463
2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA ea024744201ex99-1_gelteq.htm EX-99.1 141923
3 CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED DECEMBER 31 ea024744201ex99-2_gelteq.htm   iXBRL EX-99.2 694880
9 GRAPHIC ex99-2_001.jpg GRAPHIC 1394
  Complete submission text file 0001213900-25-059678.txt   5479867

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gels-20241231.xsd EX-101.SCH 99198
5 XBRL CALCULATION FILE gels-20241231_cal.xml EX-101.CAL 48604
6 XBRL DEFINITION FILE gels-20241231_def.xml EX-101.DEF 276718
7 XBRL LABEL FILE gels-20241231_lab.xml EX-101.LAB 557121
8 XBRL PRESENTATION FILE gels-20241231_pre.xml EX-101.PRE 302112
117 EXTRACTED XBRL INSTANCE DOCUMENT ea0247442-6k_gelteq_htm.xml XML 809539
Mailing Address LEVEL 4 100 ALBERT ROAD SOUTH MELBOURNE VIC C3 3205
Business Address LEVEL 4 100 ALBERT ROAD SOUTH MELBOURNE VIC C3 3205 61390873990
Gelteq Ltd (Filer) CIK: 0001920092 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-42373 | Film No.: 251092331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)